Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Siqun Zheng"'
Autor:
Thiago Vidotto, Eddie L. Imada, Farzana Faisal, Sanjana Murali, Adrianna A. Mendes, Harsimar Kaur, Siqun Zheng, Jianfeng Xu, Edward M. Schaeffer, William B. Isaacs, Karen S. Sfanos, Luigi Marchionni, Tamara L. Lotan
Publikováno v:
JCI Insight, Vol 8, Iss 3 (2023)
The genomic and immune landscapes of prostate cancer differ by self-identified race. However, few studies have examined the genome-wide copy number landscape and immune content of matched cohorts with genetic ancestry data and clinical outcomes. Here
Externí odkaz:
https://doaj.org/article/ecd843645058485e9f5dc48d24f26852
Autor:
Michael J. Northcutt, Zhuqing Shi, Michael Zijlstra, Ayush Shah, Siqun Zheng, Eugene F. Yen, Omar Khan, Mohammad Imran Beig, Polina Imas, Adam Vanderloo, Obaid Ansari, Jianfeng Xu, Jay L. Goldstein
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Single nucleotide polymorphism (SNP)-based polygenic risk scoring is predictive of colorectal cancer (CRC) risk. However, few studies have investigated the association of genetic risk score (GRS) with detection of adenomatous poly
Externí odkaz:
https://doaj.org/article/b7a44f8c28f5494c91b4f7454a98eb10
Autor:
Ethan M Lange, Anna M Johnson, Yunfei Wang, Kimberly A Zuhlke, Yurong Lu, Jessica V Ribado, Gregory R Keele, Jin Li, Qing Duan, Ge Li, Zhengrong Gao, Yun Li, Jianfeng Xu, William B Isaacs, Siqun Zheng, Kathleen A Cooney
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e93436 (2014)
Prostate cancer is the most common non-skin cancer and the second leading cause of cancer related mortality for men in the United States. There is strong empirical and epidemiological evidence supporting a stronger role of genetics in early-onset pro
Externí odkaz:
https://doaj.org/article/98d573dd13d54d61b2bd7817179e867d
Autor:
Northcutt, Michael J., Zhuqing Shi, Zijlstra, Michael, Ayush Shah, Siqun Zheng, Yen, Eugene F., Khan, Omar, Beig, Mohammad Imran, Imas, Polina, Vanderloo, Adam, Obaid Ansari, Jianfeng Xu, Goldstein, Jay L.
Additional file 1: SupplementaryTable 1. Known risk-associated SNPs for colorectal canceravailable from Affymetrix Axiom™Biobank Plus Genotyping Array.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::183971994b1b08f4065861d90e8e85b9
Publikováno v:
AOPC 2020: Optical Spectroscopy and Imaging; and Biomedical Optics.
Autor:
Michael Northcutt, Zhuqing Shi, Michael Zijlstra, Ayush Shah, Siqun Zheng, Eugene Yen, Omar Khan, Mohammad Imran Beig, Polina Imas, Adam Vanderloo, Obaid Ansari, Jianfeng Xu, Jay Goldstein
Background: SNP-based polygenic risk scoring is predictive of colorectal cancer (CRC) risk. However, few studies have investigated the association of genetic risk score (GRS) with detection of adenomatous polyps at screening colonoscopy. Methods: We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2148e7fc91d2dde205a66c78e3e3467
https://doi.org/10.21203/rs.3.rs-62371/v1
https://doi.org/10.21203/rs.3.rs-62371/v1
Autor:
Marta Gielzak, Patrick C. Walsh, Kathleen E. Wiley, Shuwei Li, Brice A. J. Sarver, Hongjie Yu, Tamara L. Lotan, Rong Na, Mary Helen Black, Brian T. Helfand, Yishuo Wu, William B. Isaacs, Siqun Zheng, Kathleen A. Cooney, Jianfeng Xu, Holly LaDuca
Publikováno v:
Journal of Urology. 203
Autor:
Jianfeng Xu, Richard J Fantus, Brian T. Helfand, Kathleen A. Cooney, Siqun Zheng, Yishuo Wu, Zhuqing Shi, William B. Isaacs, Jun Wei
Publikováno v:
Journal of Urology. 203
Autor:
Kristian Novakovic, Jianfeng Xu, Zhuqing Shi, Sangtae Park, Richard J Fantus, Siqun Zheng, Jun Wei, Haifei Jia, Brian T. Helfand
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:About 38% of kidney cancer risk can be attributed to inherited factors. Several candidate kidney cancer susceptibility genes have been proposed. However, statistical evid...
Autor:
Adrianna A. Mendes, Jiayun Lu, Harsimar B Kaur, Siqun Zheng, Jianfeng Xu, Edward M. Schaeffer, Karen S. Sfanos, Janielle Maynard, Ashley E. Ross, Steven P. Balk, Mary-Ellen Taplin, Emmanuel S. Antonarakis, Corinne E. Joshu, Eugene Shenderov, Tamara L. Lotan
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:PO-100
Background: B7-H3 (CD276, PD-L3) is an immunomodulatory molecule highly expressed in prostate cancer and belonging to the B7 superfamily that also includes PD-L1 (B7-H1). Immunotherapies (antibodies, antibody-drug conjugates, and CAR-T cells) targeti